Sirnaomics (HKSE:02257) Days Sales Outstanding : 0.00 (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Sirnaomics Days Sales Outstanding?

Sirnaomics's average Accounts Receivable for the six months ended in Jun. 2024 was HK$0.00 Mil. Sirnaomics's Revenue for the six months ended in Jun. 2024 was HK$0.00 Mil.

The historical rank and industry rank for Sirnaomics's Days Sales Outstanding or its related term are showing as below:

HKSE:02257's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 70.69
* Ranked among companies with meaningful Days Sales Outstanding only.

Sirnaomics's Days Sales Outstanding stayed the same from Jun. 2023 (0.00) to Jun. 2024 (0.00).

Sirnaomics Days Sales Outstanding Historical Data

The historical data trend for Sirnaomics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirnaomics Days Sales Outstanding Chart

Sirnaomics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Sirnaomics Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Days Sales Outstanding	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of Sirnaomics's Days Sales Outstanding

For the Biotechnology subindustry, Sirnaomics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sirnaomics's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sirnaomics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Sirnaomics's Days Sales Outstanding falls into.

Sirnaomics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Sirnaomics's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Sirnaomics's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding (Q: Jun. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Jun. 2024 ))	/	count )	/	Revenue (A: Jun. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 2
=	0					/	0	*	365 / 2
=	N/A

Sirnaomics (HKSE:02257) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Sirnaomics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Sirnaomics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Sirnaomics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirnaomics Ltd (HKSE:02257) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.218 Xinghu Street, Unit 415, A4 Building, Suzhou Industrial Park, Suzhou, CHN

Website

https://www.sirnaomics.com

Sirnaomics Ltd is a therapeutics biopharmaceutical company with product candidates in preclinical and clinical stages that focuses on the discovery and development of drugs for indications with medical needs and large market opportunities. The Group's operations and non-current assets are located at the United States of America and the mainland of the People's Republic of China.

Executives

Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Dai Xiaochang	2201 Interest of corporation controlled by you
Lu Yang	2101 Beneficial owner
Yan Xia Ling	2202 Interest of your spouse
Ceng Yu	2201 Interest of corporation controlled by you
Li Jie	2201 Interest of corporation controlled by you
Li Lele	2202 Interest of your spouse
Shanghai Chongshi Enterprise Management Partnership(lp)	2101 Beneficial owner
Shenzhen Qianhai Rotating Boulder Fund Management Co.,ltd	2201 Interest of corporation controlled by you
Shenzhen Rotating Boulder Tiancheng The Second Investment Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Shenzhen Rotating Boulder Tiancheng The Third Investment Partnership (limited Partnership)	2201 Interest of corporation controlled by you

Sirnaomics Headlines

No Headlines